Author

Eric Gregory Olinger

Cliniques Universitaires Saint-LucORCID 0000-0003-1178-7980Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Approach:experimental assay· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Organism:mouse· 1

Frequent Co-Authors

Anthony J. BleyeriD· 2 shared Céline SchaefferiD· 2 shared Elhussein A. E. ElhassaniD· 2 shared Guglielmo SchianoiD· 2 shared Holly R. MabillardiD· 2 shared John Andrew SayeriD· 2 shared Kendrah O. KiddiD· 2 shared Luca RampoldiiD· 2 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Anthony J. BleyerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genetic & Genomic MedicineBMC NephrologyPeer-reviewedDec 18, 2024

Eight-Fold Increased COVID-19 Mortality in Autosomal Dominant Tubulointerstitial Kidney Disease due to MUC1 Mutations: An Observational Study

Kendrah O. Kidd, Adrienne H. Williams, Abbigail Taylor…·Anthony J. Bleyer

This study finds that individuals with ADTKD-MUC1 have an eight-fold higher risk of COVID-19 mortality compared to ADTKD-UMOD individuals, possibly due to reduced mucin-1 production.

1 citation

humanstatistical model

𝕏 PostBluesky

GeneticsbioRxivPreprintSep 13, 2022

Allelic and Gene Dosage Effects Involving Uromodulin Aggregates Drive Autosomal Dominant Tubulointerstitial Kidney Disease

Guglielmo Schiano, Jennifer L. Lake, Marta Mariniello…·Olivier Devuyst

This study investigates allelic and gene dosage effects of UMOD mutations in ADTKD, showing toxic aggregates and ER stress contribute to kidney disease progression.

DOI 10.1101/2022.09.13.507770

mouseexperimental assay

𝕏 PostBluesky

Genetic & Genomic MedicineProceedings of the National Academy of SciencesPeer-reviewedAug 10, 2022

An intermediate effect size variant in UMOD confers risk for chronic kidney disease

Eric Gregory Olinger, Céline Schaeffer, Kendrah O. Kidd…·Magdalena Zarowiecki

The paper identifies an intermediate-effect variant in UMOD associated with chronic kidney disease risk and shows it has reduced disease severity compared to canonical ADTKD mutations.

49 citationstop 2%

humanGWAS summary statistics

𝕏 PostBluesky